Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001655759-24-000103
Filing Date
2024-06-26
Accepted
2024-06-26 16:19:14
Documents
4
Period of Report
2024-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1719433147.html 3  
1 FORM 3 wk-form3_1719433147.xml 3 1674
2 EX-24.1 complete_withxdocusignxs.htm EX-24.1 5454
3 complete_withxdocusignxs001.jpg GRAPHIC 309111
4 complete_withxdocusignxs002.jpg GRAPHIC 39341
  Complete submission text file 0001655759-24-000103.txt   488821
Mailing Address 640 LEE ROAD CHESTERBROOK PA 19087
Business Address
Saik Andrew (Reporting) CIK: 0001616284 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38672 | Film No.: 241073671

Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Issuer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)